Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Concert Pharmaceuticals
Age
18–60
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Non-smoker who has not used nicotine-containing products for at least 3 months prior to the first dosing and throughout the study
Body mass index (BMI) ≥ 18.0 and ≤ 32.0 kg/m2 at Screening
Medically healthy with no clinically significant medical history, physical examination, laboratory profiles, vital signs or ECGs
If of reproductive age, willing and able to use a medically highly effective form of birth control 30 days prior to first dose, during the study and for 30 days following last dose of study medication
Understands the study procedures in the informed consent form, and be willing and able to comply with the protocol
You may not be if
History or presence of clinically significant medical or psychiatric condition or disease
History of any illness that might confound the results of the study or poses an additional risk to the subject by their participation in the study
History or presence of alcohol or drug abuse within the past 2 years prior to the first dosing
Females who are nursing, pregnant, or planning to become pregnant while in the study, and for 30 days after last dose of study drug
Positive results at Screening for human immunodeficiency virus (HIV), hepatitis B surface antigen (HBsAg) or hepatitis C virus (HCV)
A positive test or history of incompletely treated or untreated tuberculosis
Donation of \> 499 mL of blood or plasma within 56 days of Screening (during a clinical trial or at a blood bank donation) and for 30 days after last dose of study drug
